Active leadership and unity for all members to thrive in the evolving hematology oncology community
Menu
About
Mission
Benefits
Board of Directors
Committees
Join
Corporate Allies
Legislative
Newsletters
Presentations
COVID-19 Information
Member Login
Latest News
Daiichi Sankyo, Inc. New Resources for Injectafer
read more >
CMS Most Favored Nation Fee Schedule Halted
read more >
CMS Most Favored Nation
Most Favored Nation Model for Medicare Part B Drugs and Biologicals Interim Final Rule with Comment Period
read more >
